PFE’s labs should continue trying to discover drugs, but shareholders shouldn’t be put in the position of relying on an R&D hot streak to earn a decent return on their investment. That’s why I’m beating the drug for increasing the financial leverage.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”